Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Nutmeg alcohol appears in some of the more fascinating corners of the story of medicinal plant extracts. Ancient practitioners recognized the aromatic nut from Myristica fragrans as far more than a culinary curiosity. As centuries rolled forward into the period of pharmacopeia codification, scientists carved out standards—later known as BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia)—that gave nutmeg alcohol a proper seat at the pharmaceutical table. Before the microscope and mass spectrometer, people relied on distillation and sharp nose to judge the essence. Rigorous quality laws, standardized testing, and clinical safety assessments cleared the path for the modern pharma-grade version that today finds its way onto ingredient lists around the world.
Pharma grade nutmeg alcohol draws its chemical backbone straight from the essential oil of nutmeg. Known by chemists as 4-terpineol among other names, this clear to pale yellow liquid clocks in with a characteristically woody, earthy aroma. Manufacturers bring the product up to a benchmarked purity—every batch vetted against the tight requirements set by BP, EP, and USP. Safe handling matters deeply here, since quality shortfalls can lead to unexpected safety or consistency issues downstream. An established distributor serves pharmaceutical processors and R&D labs as well as firms in the food flavor business, but not all nutmeg alcohol is fit for use where human health is on the line—hence the “pharma grade” tag.
Dense as conversation at a busy apothecary, nutmeg alcohol’s physical and chemical specs read like a scientific checklist: Boiling point hovers around 210°C, melting point falls close to 32°C, and density at standard temperature lands near 0.99g/cm³. Refractometric indices matter for purity control—after all, subtle changes point straight to contamination or adulteration. The alcohol doesn’t dissolve equally in all solvents, showing a special affinity for alcohol and oils over water. Chemically, the molecule wears a single hydroxyl group, making it susceptible to oxidation and esterification reactions, which can alter scent, solubility, or stability.
In every pharma-grade warehouse and factory, technical specs become the last word in liability and trust. Purity doesn’t just sit at the top of the checklist; it drives nearly every decision, typically above 98%. Moisture, residual solvents, and specific gravity stay under strict surveillance—analytical chemists pore over chromatograms and distillation residues. Labeling must keep pace with modern regulations: batch numbers, manufacturing dates, expiry windows, and safety data follow international harmonized systems. This attention to detail spells the difference between GMP (Good Manufacturing Practice) compliance and regulatory headaches. Every step of the production chain gets tracked and recorded, boosting traceability and accountability.
The substance makes its debut through steam distillation of nutmeg seeds. Distillation extracts a medley of volatile compounds, then fractionation and vacuum distillation separate nutmeg alcohol from less desirable byproducts such as myristicin and safrole. Since pharma grade asks for higher purity, repeated distillation and sometimes chromatography get called in. Trash in, trash out—so processors start with well-sourced, mature seeds, and every shipment comes with identity and pesticide residue test data. Solvent traces must wash away completely, since pharmaceutical bottlers can’t risk chemical cross-talk in their finished formulas. Processors perform every step in controlled, GMP-audited rooms to prevent adulteration, contamination, or product mix-ups.
Chemists put nutmeg alcohol through its paces in the lab. Oxidation with chromic acid or potassium permanganate, for instance, transforms the alcohol into a ketone or carboxylic acid, changing properties and expanding its utility. Esterification, where the hydroxyl group swaps partners with an acid chloride or anhydride, creates aroma-rich esters used by perfumers and flavorists. Hydrogenation smooths rough edges, sometimes enhancing stability for storage or food contact. Every modification comes with its own regulatory pathway, since pharma-grade products must prove both safety and benefit for each new derivative. Rarely does a compound from a simple kitchen spice carry the chemistry workload that nutmeg alcohol manages.
Science books and safety sheets list this alcohol under an array of aliases: 4-terpineol, 4-isopropyl-1-methyl-1-cyclohexen-4-ol, and “Bulnesia terpene alcohol”. Marketers may also call it nutmeg camphor or myristicin alcohol, depending on provenance and composition. These variations can confuse the unwary buyer—mislabeling risks either a botched application, or worse, a regulatory nonconformance. Training staff to check CAS numbers (usually 562-74-3) and cross-reference synonyms keeps operations smooth. Pharmaceutical formulators stick to the precise IUPAC name where possible, but the flavor and fragrance crowd leans heavily on familiar commercial labels.
Even a natural extract like nutmeg alcohol can carry safety concerns. Inhalation, ingestion, or skin exposure in concentrated, undiluted form may result in dizziness, nausea, or irritation. Some studies show hepatotoxic risks at higher doses, likely due to residual myristicin or related compounds if purification gets sloppy. Operators must wear gloves, goggles, and, in the case of large-scale decanting, use fume extraction or similar engineering controls. Documentation sits at the core of any pharma-grade product’s journey: material safety data sheets, certificates of analysis, GMP audit trails, and chain-of-custody logs. Regulatory inspectors expect to see everything from risk assessments to emergency first-aid protocols online and up to date. Staff training and regular drills on product handling and accident management can make the difference between a near miss and a reportable incident.
Nutmeg alcohol walks a line between ancient herbalist tradition and high-stakes modern science. Pharmaceutical firms sometimes tap its properties as a mild expectorant, carminative, or flavoring ingredient in syrups and lozenges, taking care to dose within regulatory limits. Beyond health care, food technologists and candy makers sometimes use pharma grade as a flavor enhancer for baked goods or beverages, aiming for that uniquely warm, spicy nuance without the bitterness of whole nutmeg. In perfumery and personal care, formulators value the alcohol for its fixative powers—helping a fragrance linger rather than evaporate in a flash. Labs run stability tests to prove it plays well with acids, bases, and a range of excipients—since nobody wants an ingredient to turn sour or go off before shelf life ends.
Recent years have seen a spike in studies exploring nutmeg alcohol’s pharmacological footprint. Scientists dig into anti-inflammatory and antimicrobial effects that might offer alternatives to conventional actives. These investigations don’t just try to explain ancient folk remedies, but chip away at how nutmeg derivatives interact with enzymes, cell membranes, and even the human microbiome. Novel delivery systems emerge from this research: microencapsulation, cyclodextrin complexes, and slow-release gels give formulators more control. Labs keep pushing to minimize side effects, increase absorption, and uncover new synergistic pairings—perhaps with other terpenoids or vitamins. Collaboration with toxicologists and regulatory scientists is crucial, as every data point matters for future product labels and patient trust.
Safety researchers dig for any signal that nutmeg alcohol should appear on their “watch” lists. Animal studies and, on rare occasions, clinical reports show that high doses or repeated misuse can provoke liver anomalies, neurotoxic symptoms, or allergic responses. Classics like the LD50 (lethal dose for 50% of subjects) form just the starting line—more nuanced work parses out margin of safety, the potential for bioaccumulation, and metabolite profiles. Consistent, reproducible data guides regulatory agencies as they set exposure limits and require post-market surveillance. In practice, following the established guidelines shaves risk to nearly zero, but researchers continue to explore long-term effects, and pressure exists to lower trace solvent levels and improve analytical sensitivity.
Curiosity about bio-based fine chemicals, clean label products, and natural flavorings opens up fresh opportunities for nutmeg alcohol. Plant-based medicines are earning more respect in Western healthcare systems, thanks to rigorous evidence and the rising demand for alternative therapies. Synthetic alternatives still fill much of the market, but “green chemistry” supporters push for natural production routes, rethinking old isolation methods and tightening impurity controls. As computational chemistry and machine learning blend into ingredient discovery, nutmeg derivatives could find wider roles in neuroprotective drugs or next-generation fragrances. Any step forward must go hand in hand with clear risk communication and responsible marketing, ensuring that tradition and modern science support—not contradict—each other.
Nutmeg alcohol comes from the essential oil of nutmeg, a spice that’s traveled across kitchens worldwide for centuries. This alcohol is not just a culinary treat—extracting it at pharma grade purity brings the standards way up. “BP EP USP” signals compliance with British, European, and US pharmacopoeias, so we’re talking about a product that matches the highest purity and consistency requirements demanded by modern medicine.
What stands out most is its chemical structure. Nutmeg alcohol’s unique composition, rich in monoterpenes and phenolic compounds, opens doors not only in flavoring but also in wellness products. In my years researching plant-based compounds for natural health products, I’ve seen nutmeg alcohol used to bridge the gap between tradition and science.
Meeting pharma grade targets takes careful manufacturing and constant lab checks. No batch slips through without a long series of purity tests. Without rigorous testing, unwanted impurities could taint a drug, risking patient safety. Regulators demand this attention to detail— and properly so. Safety is non-negotiable.
It’s easy to see why manufacturers want this purified form. Nutmeg alcohol helps keep consistency in products. In pharmaceuticals, consistency isn’t just nice to have; it’s a basic demand. Safe medicines start with safe ingredients.
This compound finds most of its fame in flavoring and fragrance. Chewable tablets and syrups benefit from a bit of nutmeg’s warmth and sweetness, masking the bitter bite of active pharmaceutical ingredients. For children and adults alike, flavor can mean the difference between sticking to a treatment plan or skipping doses.
Nutmeg alcohol also makes waves in topical and oral care products. Its scent and mild antibacterial qualities give it a place in toothpastes, mouthwashes, and traditional oil-based remedies. Seeing herbalists and pharmacists blend old techniques with today’s cleanliness standards reminds me there’s much more to these ingredients than their aroma.
Pharma grade nutmeg alcohol answers a call for natural product options within big healthcare companies and independent formulators alike. People want shorter, more familiar ingredient lists. That’s not just a niche demand. American Botanical Council surveys show steady year-on-year growth in both consumer and professional interest for plant-based medicine.
Still, safety needs attention. Myristicin, a compound in nutmeg oil, can be toxic in large doses—a fact easy to overlook if the focus stays on all things natural. Strict pharma standards protect against these kinds of risks. By mandating careful isolation and precisely measured concentrations, regulators help avoid unwanted effects.
There’s a tough balance between leveraging the benefits of natural ingredients and protecting health through strict quality standards. Nutmeg alcohol, with its long story and modern applications, highlights this challenge well. Quality comes from skilled sourcing, transparent manufacturing, and clear labeling.
Health professionals and researchers can keep pushing for better communication on plant-based pharmaceuticals. Well-run clinical trials on natural excipients could back up traditional use with sound science. And manufacturers with proven supply chains earn trust in a field that sometimes struggles with counterfeit or contaminated products.
For now, nutmeg alcohol pharma grade shows that even the most familiar kitchen staples can transform into key players in health innovation, provided every step from farm to pharmacy passes inspection.
Specifications matter. Anyone who’s spent time in manufacturing, quality assurance, or even procurement knows the ripple effect of a poorly defined standard. I remember watching a project stall for weeks simply because two suppliers interpreted the same product grade in opposite ways. For something as basic as a raw material, a few missing details on composition or particle size could mean entire batches declined by QA, budgets busted, customers unhappy.
A good set of specs isn’t a luxury. It is the blueprint that keeps everyone aligned from the chemist to the warehouse picker. These details clear up confusion before a single drum arrives at the gate. Critical points often include minimum assay (how much of the main ingredient is actually there), common impurities, moisture content, and other characteristics like pH, solubility, or odor. Mistakes here cost real money. In the world I came up in, I’ve seen plants chase down strange colors or odors, just to find out they received an off-grade product someone else shrugged at.
High purity is not just about marketing. Purity matters for performance, health, and often for legal reasons. Take pharmaceutical ingredients. The U.S. Pharmacopeia and similar bodies publish standards that literally spell out how much impurity is allowed, often in parts per million. These bodies use real-world data, updating acceptable impurity levels when new risks emerge. An impurity that passes under the radar in food processing can become a disaster in injectable medicines.
In food manufacturing, global regulators like the FDA or EFSA require clear labeling of purity and contaminants. My first job involved managing shipments of a vitamin powder that had to meet a hundred different criteria—everything from heavy metals to mold spore counts. If any count spiked, the entire batch got pulled, no questions asked.
Documents like Certificates of Analysis prove what’s in the drum or bag. These aren’t just paperwork. A trusted COA reassures buyers and helps regulatory bodies track safety. I learned early to check COAs for every detail, and not just scan for a signature. The smart companies test random samples before products ever hit their lines, because once contaminated material touches large-scale equipment, cleanup is messy and costs thousands.
Audits make a difference. Long-term players send their own teams to supplier factories, demanding upstream traceability of raw materials. This step builds confidence in buyers and helps knock out fakes and counterfeits—a growing problem as the supply chain stretches across borders. I’ve seen small companies bounce back from safety recalls by tightening specs and document controls. The big names go public with their standards and third-party testing, letting customers know nothing is left to chance.
Stricter standards don’t need to slow down progress. Clear, shared specifications help even new suppliers compete, since everyone knows what’s required and nothing gets lost in translation. Automated lab equipment and digital tracing systems make it much easier for producers to show their work and catch problems before they spread. As blockchain and AI shape future traceability, that same attention to clear specifications and purity standards keeps the spotlight on quality, not just speed.
Nutmeg alcohol isn’t just a fragrance in candles; inside the world of pharmaceuticals, it’s seen as a solvent, flavor, and sometimes an active agent. Safe use matters. When a product comes labeled as BP, EP, or USP, it signals the ingredient meets standards from British, European, or United States Pharmacopeia. These agencies don’t rubber-stamp substances. They design tough tests, looking at purity, identity, and contamination.
Contamination causes many drug recalls, and even rare impurities can hit patient safety hard. I've read the fine print on these pharmacopeia standards—it isn’t just about chemical composition. They dig into possible byproducts, microbial content, and residue from manufacturing. Reputable pharma suppliers provide certificates of analysis, batch records, and traceability proof. Sometimes, I’ve seen companies run their own third-party verification, even if a batch carries the BP, EP, or USP badge.
People sometimes assume natural equals safe. In nutmeg’s case, plants often hold compounds like myristicin and safrole, which can act as psychoactives or even toxins in the wrong dose. Pharmaceutical nutmeg alcohol must not just be pure—it must stay within toxicological thresholds set by regulators. The FDA, EMA, and other leaders cap contaminants and keep a close watch on cumulative doses in medicinal products.
Let’s ground this in real outcomes. A batch of subpar ingredient can ruin a drug’s safety reputation. Class-action lawsuits rarely stem from a single failure, but from patterns traced back to ignored standards. No pharma company can afford that. Patients rely on strict compliance. Supply chain teams that do their homework—verification, documentation, independent testing—limit risk before it’s baked into the final product.
Nutmeg alcohol figures into various products: oral suspensions, topical creams, sometimes taste-masking agents. At every step, quality control keeps the process honest. Modern pharma production lines rely on GMP protocols. I've toured labs where technicians check every incoming lot for consistency, run chemical assays, and log anomalies. It’s a grind, but these steps catch issues before they multiply.
Cutting corners won’t work for anyone in this industry. If there’s doubt about a supplier’s quality, procurement teams should ask for transparent documentation: comprehensive batch records, third-party laboratory results, or recent regulatory audits. Digital tracking gets better every year. A blockchain-backed chain of custody, for example, gives every party a live ledger, minimizing fraud.
Most recalls or scandals stem from avoidable shortcuts: mixing grades to cut costs, skipping verifications, or overlooking regulatory updates. I’d urge any pharma professional to build real relationships with certified, vetted suppliers. Stay curious. Keep up with regulatory shifts and scientific findings about nutmeg alcohol’s biological actions. Patient trust isn’t just built in the lab; it grows in every buying decision and every test result.
Nutmeg alcohol, labeled with BP, EP, or USP, has a vital role—once it consistently passes purity checks, safety reviews, and regulatory eyes. Patients deserve transparency. Their safety comes from a mix of science, vigilance, and a stubborn refusal to cut corners.
Nutmeg Alcohol used in the pharmaceutical industry—carrying the BP, EP, and USP tags—draws a line between average and top-tier products. This liquid has a real world job to do, so the way it's handled behind the scenes matters for every formulation that lands on a pharmacy shelf. Storage stands as one place where experience and science jostle for space. I’ve seen the results when corners get cut: batch recalls, spoiled stock, and more paperwork than anyone wants to face.
Anybody in pharma knows: some raw ingredients shrug off a rough environment, but nutmeg alcohol doesn’t give that kind of forgiveness. Heat and sunlight set up a chain reaction, speeding up oxidation and inviting breakdown of the compound. That chemic change spells trouble for drug stability and safety. Nutmeg alcohol belongs in a place protected from direct light, tucked into a cool spot—room temperature or a little lower stays safe. Steady temperature helps keep consistency. Sudden swings invite condensation, which nobody wants in a drum of pharma-grade raw material.
Packaging makes a difference. I’ve seen companies try to get away with low-grade plastics or open mouth drums. Not worth the risk, for the simple reason that nutmeg alcohol starts picking up impurities from containers that aren’t designed for solvent resistance. High-density polyethylene, amber glass, or stainless steel containers hold up best, and tight seals go a long way toward stopping any outside air or moisture from sneaking in and making trouble.
Regulators pay close attention to traceability for every incoming and outgoing drum, and pharma buyers expect nothing less. Clear labeling sidesteps confusion and shows up clearly in audits. Each bottle or drum should have batch number, expiry date, and supplier name visible without guesswork. This isn’t just bureaucracy—if a storage issue comes up, fast traceability keeps issues contained without dragging down a whole facility’s operation.
Nobody can afford to treat storage as “set it and forget it.” If staff don’t understand why cool, dry, and dark conditions matter, shortcuts creep in. I’ve led trainings where staff got practical lessons—real-life examples of product loss from careless storage—and buy-in grew overnight. Pharma needs that level of diligence to protect patients on the other end of the chain.
Maintaining a dedicated area for volatile solvents helps avoid cross-contamination. Some facilities use HVAC systems set just for chemical storage rooms. Routine inspection and temperature logging stop small issues from becoming big ones. Investment in good packaging, smart layout, and thorough staff training saves money, frustration, and reputation in the long run. With nutmeg alcohol, keeping a close eye on storage details simply makes everything downstream smoother and safer—for everyone involved.
Pharmacopeia standards, those acronyms like BP, EP, and USP, keep showing up on product data sheets and certificates. BP means British Pharmacopoeia, EP is the European Pharmacopoeia, and USP stands for United States Pharmacopeia. These three names carry real weight across the pharmaceutical world. They set out the basic demands for quality, safety, and consistency in ingredients and final medicines found on pharmacy shelves and in hospital cabinets. If a supplier claims their product meets these rules, they’re telling buyers their material plays by the toughest guidelines on earth.
I’ve spent enough time near pharmaceutical manufacturing to see how tight these expectations stay. One warehouse manager once remarked, “You can never just take someone’s word on this stuff—they need the paperwork.” Each time an ingredient arrives, tests kick off—identity, purity, even particulate checks. These methods follow protocols laid out by the three pharmacopeias. If the material doesn't line up exactly, the whole batch waits until the issue gets sorted.
It’s not just about ticking off regulatory boxes. Failures here can become much bigger problems—patient safety hangs in the balance. Think about medicines for heart disease or epilepsy; one contaminated vial or degraded tablet leads to real harm or even death. During training, I watched a young technician discover a batch of raw material that did not pass the BP threshold for heavy metals. The shipment got pulled before hitting production. It cost the company money, sure, but skipping a standard isn’t up for debate when people trust the result with their lives.
The World Health Organization puts up sobering numbers on incidents tied to substandard medicines. Over 10% of medical products in low- and middle-income countries are either fake or miss the quality cut-off. When global supply chains stretch further, certainty about what goes in the bottle means more. FDA warning letters keep showing how often the lack of compliance trips up even seasoned companies.
Doctors and pharmacists want assurance that an antibiotic, a blood pressure drug, or even a simple painkiller has the same strength and purity from dose to dose. That trust trickles down from the tough language in pharmacopeia standards.
Desks and factory floors should turn compliance into part of the company’s DNA, not just the paperwork in a binder. Regular, independent audits help, but a culture that rewards spotting and correcting issues goes even further. Investing in better testing technology, keeping staff training up to date, and building open channels with suppliers all have payoffs.
Some places keep electronic tracking that records every lab result back to its origin—no room for fudging numbers or quietly skirting the rules. Real compliance doesn’t end at “tick the box”—it goes deep, from plant manager to shipping clerk.
Every person who picks up a medicine expects the same result—a product made to one high, agreed standard. BP, EP, and USP build more than paperwork—they help guarantee safety, confidence, and the sense that a stranger’s hands somewhere far away are working for your health. As the world’s problems grow more complex, sticking to these rules never feels old-fashioned. It’s the backbone of real trust, from the scientist’s lab to the patient’s nightstand.
| Names | |
| Preferred IUPAC name | 4-allyl-2-methoxyphenol |
| Other names |
Myristica fragrans alcohol Nutmeg spirit Ethanolic extract of nutmeg Spiritus Nucis Moschatae Essence of Nutmeg Nutmeg tincture |
| Pronunciation | /ˈnʌt.mɛɡ ˈæl.kə.hɒl ˌbiːˈpiː ˌiːˈpiː ˌjuːˈɛsˈpiː ˈfɑː.mə ɡreɪd/ |
| Identifiers | |
| CAS Number | 4149-42-6 |
| Beilstein Reference | 3598960 |
| ChEBI | CHEBI:78722 |
| ChEMBL | CHEMBL142910 |
| ChemSpider | 71124 |
| DrugBank | DB14096 |
| ECHA InfoCard | The ECHA InfoCard for "Nutmeg Alcohol BP EP USP Pharma Grade" is: **03e2f95f-50b8-48f5-9f8e-0ebdcaf14948** |
| EC Number | 928-96-1 |
| Gmelin Reference | 4896 |
| KEGG | C16449 |
| MeSH | Diterpenes, Nutmeg Oil, Myristicin, Monoterpenes, Alcohols |
| PubChem CID | 638011 |
| RTECS number | WN0696750 |
| UNII | XA66B3X86P |
| UN number | UN1169 |
| CompTox Dashboard (EPA) | DTXSID0058482 |
| Properties | |
| Chemical formula | C11H18O |
| Molar mass | 196.29 g/mol |
| Appearance | Clear, colorless or pale yellow liquid |
| Odor | Characteristic aromatic |
| Density | 0.910 – 0.930 g/cm³ |
| Solubility in water | Insoluble in water |
| log P | 1.99 |
| Acidity (pKa) | 12.3 |
| Basicity (pKb) | 8.1 |
| Magnetic susceptibility (χ) | Diamagnetic |
| Refractive index (nD) | 1.475 – 1.488 |
| Viscosity | 20 - 35 mPa.s |
| Dipole moment | 2.75 D |
| Pharmacology | |
| ATC code | A05A |
| Hazards | |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS02, GHS07 |
| Signal word | Warning |
| Hazard statements | Hazard statements: "H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation. |
| Precautionary statements | Keep container tightly closed. Store in a cool, well-ventilated place. Avoid contact with eyes, skin and clothing. Do not breathe vapour or mist. Wash thoroughly after handling. Use personal protective equipment as required. |
| Flash point | Approximately 93°C |
| Autoignition temperature | 405°C |
| LD50 (median dose) | > nutmeg oil oral rat LD50: 2470 mg/kg |
| NIOSH | Not Listed |
| PEL (Permissible) | 10 mg/m³ |
| REL (Recommended) | 250 mg |
| Related compounds | |
| Related compounds |
Nutmeg Oil Myristicin Elemicin Safrole Isosafrole Nutmeg Ether Myristic Acid |
Chengguan District, Lanzhou, Gansu, China
